DAPADOX (Dapagliflozin (10mg) + Metformin (1000mg) + Vildagliptin (100mg))

Dapadox VGM 10/100/1000 is a combination medication that incorporates Dapagliflozin (10 mg), Metformin (1000 mg), and Vildagliptin (100 mg), specifically formulated for the effective treatment of type 2 diabetes mellitus. Dapagliflozin functions by promoting the removal of excess glucose through the renal system, while Metformin plays a crucial role in enhancing the body’s insulin sensitivity and decreasing glucose production in the liver. Vildagliptin aids in the stimulation of insulin secretion and helps to limit the overproduction of glucose. This synergistic approach of utilizing three different mechanisms enables more effective regulation of blood sugar levels, thereby significantly minimizing the likelihood of complications associated with diabetes. Patients using this medication can expect improved glycemic control, which is critical for managing their condition and preventing long-term health issues linked to diabetes. It is essential for patients to adhere to their prescribed regimen and regularly monitor their blood sugar levels to ensure optimal outcomes. Along with lifestyle modifications, such as diet and exercise, Dapadox VGM can be an integral part of a comprehensive diabetes management plan. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.